Bharat Biotech's intra-nasal Covid vaccine Innovaccer has received government approval for use as a booster dose in the country-wide mass inoculation program.
Bharat Biotech's intra-nasal Covid vaccine will be rolled out in india as approved by union Health Ministry.
Hyderabad based Bharat Biotech's nasal vaccine will now be included in the vaccination programme as a booster for 18 years.
The new form of vaccine INCOVACC has been approved by the drugs controller general of india.
This nasal vaccine will be used as a nasal apray not in the injection form.
The nasal vaccine will only be available at private health centres and will be introduced on the Co-WIN platform
The needle free vaccine will be available to all eligible adults and people are required to play for its administration
This nasal vaccine will target the nasal pathway, the site where the Sars-CoV-2 first infects the body and creates a protective coat of antibodies
The dose has been developed by the Washington University School of Medicine in St.Louis
Next: What is BF-7? Know Symptoms, Precautions of highly infections Covid.